Recruiting studies: Diarrhea Infectious

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT06498817 Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
Phase N/A · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT03895593 Preventative Intervention for Cholera for 7 Days
NA · 2 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT05166850 Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Diseas
Phase 2 · 1 location(s) · Eveliqure Biotechnologies GmbH · NCT07049159 Coupons for Safe Water Project
NA · 2 location(s) · University of Chicago · NCT05766826 Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Phase 2 · 2 location(s) · University of Virginia · NCT04305769 Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Phase 1 · 1 location(s) · University of Oxford · NCT05959616 InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
Phase 1 · 1 location(s) · Leiden University Medical Center · NCT05961059 Fecal Microbiota Transplantation for C Diff Infection
NA · 1 location(s) · Englewood Hospital and Medical Center · NCT01905709 Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories
Phase N/A · 1 location(s) · University of Zimbabwe · NCT07195006 Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Phase 4 · 5 location(s) · Bausch Health Americas, Inc. · NCT07285785 Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults
NA · 1 location(s) · Sheba Medical Center · NCT06907498 VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Phase 3 · 215 location(s) · Vedanta Biosciences, Inc. · NCT06237452 First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Yo
Phase 1 · 1 location(s) · Inventprise Inc. · NCT07205926 Fecal Microbiota Transplantation for IBS
Phase 2 · 1 location(s) · Madhusudan (Madhu) Grover, MBBS · NCT05776914 The Impact of Shigellosis and Recommended Treatment in Children
Phase 2 · 4 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT07433426 Washed Microbiota Transplantation for Clostridioides Difficile Infection
Phase N/A · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT06106698

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.